HHS expands access to buprenorphine for opioid use disorder

HHS has released new guidance that the agency said will improve access to medication-assisted treatment for opioid use disorder.Specifically, physicians with a Drug Enforcement Administration (DEA) registration number are no longer required to apply for a separate waiver to prescribe buprenorphine for opioid use disorder (OUD) treatment. The guidance states that eligible physicians:“This is a huge step in the direction that we think is appropriate,” Adm. Brett P. Giroir, MD, assistant secretary for health at HHS, said in a conference call with reporters. “But … this is notRead More

Share on facebook
Share on twitter
Share on linkedin